Barclays Cuts PT on Stryker Corporation (SYK), Calls Q1 Results Mixed
Stryker Corporation (NYSE:SYK) is one of the best robotic surgery stocks to buy.
Stryker Corp (SYK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 3,061,416 | $1,005,950,683 | -17% | 7.84% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,555,638 | $511,167,090 | +242% | 0.28% |
| 3. | AQR Capital Management Cliff Asness | 972,085 | $317,405,334 | +253% | 0.15% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 630,236 | $207,089,247 | +2823% | 0.21% |
| 5. | D E Shaw D. E. Shaw | 600,768 | $197,406,357 | +23% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $191.94 | 53 | $10,172.82 | 22,070 | 2020-07-31 | Filing | |
| $190.09 | 51 | $9,694.34 | 21,080 | 2020-04-30 | Filing | |
| $216.67 | 45 | $9,750.21 | 20,912 | 2020-01-31 | Filing | |
| $216.77 | 40 | $8,670.78 | 20,867 | 2019-10-31 | Filing | |
| $212.84 | 41 | $8,726.49 | 20,827 | 2019-07-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.22 | 125 | $38,777.50 | 10,582 | 2026-05-28 | Filing | |
| $308.79 | 258 | $79,666.53 | 10,707 | 2026-05-28 | Filing | |
| $307.30 | 1,067 | $327,885.90 | 10,965 | 2026-05-28 | Filing | |
| $306.56 | 2,809 | $861,138.28 | 12,032 | 2026-05-28 | Filing | |
| $305.66 | 165 | $50,433.90 | 14,841 | 2026-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,602,049 | $9,069,757,081 | 0.16% | |
| 2. | 22,383,181 | $7,354,889,445 | 0.18% | |
| 3. | 15,938,070 | $5,237,090,421 | 51.45% | |
| 4. | 15,596,897 | $5,086,148,490 | 0.33% | |
| 5. | 15,349,165 | $5,056,873,432 | 0.17% |
News See All
11 Best Medical Technology Stocks to Buy Right Now
One of the key conclusions in EY’s 19th annual Pulse of the MedTech Industry Report is that the global medical technology market has moved from a period of post-pandemic turbulence into one of durable...
7 Best Robotic Surgery Stocks to Buy
On May 20, Todd Sohn, Strategas Securities, appeared on CNBC’s ‘Power Lunch’ to discuss how investors should view the equity markets.
Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating
TheFly reported on May 4 that SYK saw its valuation outlook revised as Truist reduced the price target to $330 from $380 while maintaining a Hold rating on the stock.
8 Most Oversold Large Cap Stocks to Buy
Investors are increasingly focusing on identifying better entry points in high-quality companies that may have lost popularity rather than mindlessly pursuing market leaders following a robust run in ...
Stryker Corporation (NYSE:SYK) Q1 2026 Earnings Call Transcript
Operator: Welcome to the First Quarter 2026 Stryker Earnings Call. My name is Megan, and I'll be your operator for today's call.
Truist Cuts PT on Stryker Corporation (SYK) as Part of Fiscal Q1 Results Preview in MedTech
Stryker Corporation (NYSE:SYK) is one of the best medical device stocks to invest in right now.
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity markets.
UBS Revises Stryker Corporation (SYK) Outlook, Reduces Price Target but Keeps Neutral
Additionally, a cyberattack that affected Stryker Corporation (NYSE:SYK)'s operations earlier this month, on March 18, caused delays in some surgeries that depend on custom implants.
13 Best Stocks to Invest In on Robinhood for Beginners
MacroMicro reports that as of March 18, 2026, the S&P 500's forward 12-month P/E was 21.35, which was far higher than its 10-year historical average of 18.9 but slightly lower than the 22.0x reported ...